DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS

The article discussed results of the DECLARE-TIMI 58 study in the aspects of the previously finished trials (EMPA-REG OUTCOME and CANVAS). All three SGLT2i demonstrated the reduction of the risk of hospitalization for heart failure, as well as the risk of progression chronic kidney disease. At the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Marina V. Shestakova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2019
Materias:
Acceso en línea:https://doaj.org/article/7d0fd8710b2b493599155879b7a67de3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!